CHE News Alert Chemed Inc (CHE) 106.16 12/25/2014 07:41:33

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Chemed Inc (CHE) 106.16 $CHE

United States Home Health and Hospice Care Industry Analytics 2014-2021 - Market to reach $141 Billion by 2021
M2 - Mon Dec 15, 8:50AM CST
Research and Markets (http://www.researchandmarkets.com/research/8wh7p6/home_health_and) has announced the addition of Plunkett Research Ltd's new report "Home Health and Hospice Care Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 621600" to their offering. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: - Home Health and Hospice Care Industry (U.S.) to reach $131.3 billion by 2021. - Home Health and Hospice Care Industry, including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital List of Leading (Public and Private) Companies - Addus Homecare Corp - Almost Family Inc - Amedisys Inc - American HomePatient Inc - Apria Healthcare Group Inc - BioScrip Inc - Chemed Corporation - Gentiva Health Services Inc - LHC Group Inc - Lincare Holdings Inc For more information visit http://www.researchandmarkets.com/research/8w...health_and Source: Plunkett Research Ltd
CHE: 106.16 (+0.13), AFAM: 29.53 (-0.06), LHCG: 30.33 (-0.21), BIOS: 6.37 (unch), AMED: 28.97 (-0.08), GTIV: 19.07 (unch)

Quest Diagnostics' Virus Test Kit Wins FDA Clearance Again - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 12, 2:40PM CST
Studies conducted by Quest Diagnostics (DGX) over time have shown that the Simplexa test kit can offer fast, reliable results within an hour.
CHE: 106.16 (+0.13), AFAM: 29.53 (-0.06), DGX: 67.94 (-0.16), AMED: 28.97 (-0.08)

The Right Time to Invest in Amedisys (AMED)? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 09, 4:15PM CST
On Dec 8, 2014, we issued an updated research report on Amedisys Inc. (AMED).
CHE: 106.16 (+0.13), AFAM: 29.53 (-0.06), AMED: 28.97 (-0.08), GTIV: 19.07 (unch)

Chemed Corporation to Present at the Oppenheimer 25th Annual Healthcare Conference
Business Wire - Wed Dec 03, 3:00PM CST
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Oppenheimer 25th Annual Healthcare Conference on Wednesday, December 10, 2014, at approximately 8:00 a.m. (ET) at the Crowne Plaza Hotel in New York City.
CHE: 106.16 (+0.13)

Comparing America's 3 Largest Home Health Care Companies
Joseph Cafariello - at Seeking Alpha - Fri Nov 21, 6:50AM CST

CHE: 106.16 (+0.13), AMED: 28.97 (-0.08), GTIV: 19.07 (unch)

26.25% Annual Return With Lobbying Stocks? Here Is How It Works...
Dividend Yield - at Seeking Alpha - Fri Nov 21, 4:32AM CST
I found an interesting portfolio investing idea: Invest in stocks that spend a huge amount of money to support political campaigns. It's no wonder that corporations have a huge interest in spending money for politics: Each dollar should create a...
FDX: 176.42 (-0.52), CHE: 106.16 (+0.13), KND: 18.21 (+0.11), LMT: 196.43 (+0.66), ITC: 40.73 (+0.37), TXT: 43.00 (-0.28), HLS: 40.45 (+0.12), SO: 49.91 (+0.74)

Will DaVita Kidney Care Gain On Medtronic Collaboration? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 11:00AM CST
DaVita HealthCare Partners Inc.'s (DVA) division DaVita Kidney Care, a leading provider of kidney care services, announced a joint venture with Medtronic.
CHE: 106.16 (+0.13), AFAM: 29.53 (-0.06), DVA: 76.06 (+0.07), AMED: 28.97 (-0.08)

Insider Trading Alert - FIS, RP And CHE Traded By Insiders
at The Street - Tue Nov 18, 9:30AM CST
Stocks with insider trader activity include FIS, RP and CHE
CHE: 106.16 (+0.13), FIS: 63.62 (-0.42), RP: 22.51 (+0.14)

Post Earnings Update: Chemed Has Climbed 0.7% Higher in Past 2 Weeks (CHE)
Comtex SmarTrend(R) - Mon Nov 17, 8:57AM CST
18 days ago, on October 30th, 2014, Chemed (NYSE:CHE) reported its earnings. Analysts, on average, expected earnings of $1.51 per share on sales of $360.0 million. Chemed actually reported earnings of $1.48 per share on sales of $358.4 million, missing EPS estimates by $0.03 and missing revenue estimates by $1.6 million. Since the company's report, shares of Chemed have risen from $106.09 to $106.87, representing a gain of 0.7% in the past 18 days.
CHE: 106.16 (+0.13)

OJSC Cherkizovo Group: 9 Months 2014 Financial Results Announcement
Marketwired - Wed Nov 12, 5:09AM CST
OJSC Cherkizovo Group (LSE: CHE)
CHE: 106.16 (+0.13)

Chemed's board reports 174th consecutive quarterly dividend of USD0.22 per share
M2 - Mon Nov 10, 8:17AM CST
The board of directors of Chemed (NYSE:CHE), a hospice care company, on Friday declared a quarterly dividend of USD0.22 per share on the company's capital stock.
CHE: 106.16 (+0.13)

Chemed Corporation declares $0.22 dividend
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 12:41PM CST

CHE: 106.16 (+0.13)

Chemed Corporation Declares Quarterly Dividend of 22 Cents
Business Wire - Fri Nov 07, 12:18PM CST
Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 22 cents per share on the Company's capital stock, payable on December 8, 2014, to shareholders of record as of November 17, 2014. This represents the 174th consecutive quarterly dividend paid by Chemed in its 43 years as a public company.
CHE: 106.16 (+0.13)

Amsurg's Q3 Earnings Top on Revenue Growth, View Raised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 11:20AM CST
Amsurg Corp. (AMSG) reported third-quarter 2014 adjusted earnings per share (EPS) of 66 cents from continuing operations.
CHE: 106.16 (+0.13), AMSG: 54.43 (+0.41), RDNT: 9.41 (-0.08), AMED: 28.97 (-0.08)

Chemed Corporation to Present at the 2014 Credit Suisse Healthcare Conference
Business Wire - Tue Nov 04, 12:23PM CST
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the 2014 Credit Suisse Healthcare Conference on Tuesday, November 11, 2014, at approximately 11:30 a.m. (MT) at the Arizona Biltmore Hotel in Phoenix, AZ.
CHE: 106.16 (+0.13)

Chemed's (CHE) CEO Timothy O'Toole on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Oct 31, 9:10PM CDT

CHE: 106.16 (+0.13)

Chemed posts 3Q profit
Automated Insights - Thu Oct 30, 5:13PM CDT
CINCINNATI (AP) _ Chemed Corp. (CHE) on Thursday reported profit of $24.6 million in its third quarter.
CHE: 106.16 (+0.13)

Chemed misses by $0.03, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 4:20PM CDT

CHE: 106.16 (+0.13)

Chemed Reports Third-Quarter 2014 Results
Business Wire - Thu Oct 30, 3:01PM CDT
Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quarter ended September 30, 2014, versus the comparable prior-year period, as follows:
CHE: 106.16 (+0.13)

Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 4:35PM CDT

ELLI: 41.40 (+0.81), AIV: 37.80 (-0.33), EPAY: 25.23 (-0.04), CPSI: 61.11 (-0.09), LNKD: 231.83 (+0.34), ADNC: 4.15 (+0.01), CODE: 34.55 (+0.64), HME: 66.47 (-0.43), ESIO: 7.76 (+0.13), HIL: 3.69 (-0.05), DGI: 30.85 (+0.27), AHT: 10.87 (-0.04), COLM: 44.76 (-0.62), AHS: 19.89 (+0.14), CSLT: 12.14 (+0.30), FRT: 136.26 (-0.13), DGII: 9.15 (+0.15), ADUS: 23.80 (-0.19), ESS: 210.72 (-1.86), EXPE: 89.01 (+0.09), IMPV: 51.87 (+1.18), CCI: 79.05 (-0.13), CPT: 75.44 (-0.56), GB: 49.34 (-0.36), AEGR: 21.59 (-0.27), ATEN: 4.29 (+0.01), ELGX: 15.35 (-0.06), AFFX: 9.80 (+0.05), CHE: 106.16 (+0.13), BCOV: 7.88 (-0.05), DCT: 35.96 (+0.21), ELX: 5.75 (+0.03), GNMK: 13.67 (+0.06), AXTI: 2.65 (-0.09), INT: 47.79 (-0.05), EGN: 64.33 (-0.02), EGO: 5.97 (+0.18), GMED: 24.37 (+0.44), GDOT: 20.42 (+0.25), KEG: 1.73 (+0.01), ISBC: 11.14 (+0.04), GRPN: 7.89 (-0.14), ALJ: 12.54 (+0.04), CTRL: 14.57 (-0.04), GPRO: 66.41 (+4.87), EMN: 76.80 (+0.04), IMMR: 9.45 (+0.47), CUBE: 22.59 (+0.08), BYI: 83.27 (unch), ATRC: 18.76 (+0.13), BYD: 12.28 (+0.14), FLDM: 32.31 (+0.30), BEAT: 10.15 (+0.09), FLR: 60.30 (-0.26), FLT: 149.17 (-0.93), EHTH: 27.13 (+0.97)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Faex Health Adds Ebola and H. pylori AI Screening Tools

Updated Category News Views 82

A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 120

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
CVRx Lawsuit Puts Barostim Sales Claims Under Hard Scrutiny

Updated Category News Views 121

August 7 turned a compliance disclosure into a wrecking ball for CVRx shareholders. After the company revealed a Department of Justice civil investigative demand and cut its outlook, the stock dropped $3.55, or 60%, to close at $2.39. That is not a routine bad quarter getting punished. It is the market abruptly questioning whether the sales engine, the revenue it...

Continue Reading
Teva’s R&D Exit Puts Disclosure Questions in Focus

Updated Category News Views 114

An abrupt departure in the drug business is never just an HR memo. Teva Pharmaceutical Industries shares reportedly dropped about 8.74% after Eric Hughes, the company’s executive vice president of Global R&D and chief medical officer, left effective immediately. That kind of move rattles investors because R&D leadership is not decorative furniture at a pharmaceutical...

Continue Reading
Rosalind Franklin University’s $23.8M Scholarship Win

Updated Category News Views 80

Twenty-three million dollars can disappear fast in graduate health education, which is exactly why Rosalind Franklin University’s campaign result deserves more than a polite round of applause. The university’s five-year Empowering Scholars effort closed in June 2026 with $23,836,272 raised, clearing its $20 million target by roughly 19%. In a world where institutions...

Continue Reading
AMP Pushes Debt Wall to 2029 With €1.3B Green Notes

Updated Category News Views 108

A Refinancing With Some Actual Breathing Room Metal cans may be boring, but a debt wall arriving in 2028 is not—and Ardagh Metal Packaging has moved that problem down the road. AMP priced €1.3 billion of senior secured floating-rate green notes on November 20, 2026. The proceeds are earmarked to redeem $600 million of senior secured green notes due in 2028 and €450...

Continue Reading
Surfcomber Uses Art Week to Deepen Its Guest Appeal

Updated Category News Views 104

Miami Art Week can turn every hotel lobby into a billboard, but Surfcomber is at least trying to make its walls do some actual work. Kimpton Surfcomber Hotel is spreading local artists, participatory events, food, cocktails and retail across the property rather than hanging a few paintings and calling it culture. For a South Beach hotel with 200 feet of oceanfront, that...

Continue Reading
Surf City Seasons Put Vacation Rental Timing in Focus

Updated Category News Views 42

Summer’s Calendar Does the Talking School bells, not seagulls, appear to set the pace for Surf City’s rental market. Chris Rackley’s seasonal guide makes a pretty grounded point: the “best” time to visit Surf City, North Carolina, is not some universal magic week on a postcard. It depends on whether a traveler needs peak beach weather, wants elbow room, or...

Continue Reading
ECW Puts $52 Million Behind Learning Through Crisis

Updated Category News Views 66

A reserve fund for a classroom is not glamorous, but it may be the smartest detail in this whole $52 million commitment. Education Cannot Wait has announced support for more than 300,000 children in Lebanon, Myanmar and South Sudan, where war, flooding and displacement have ripped ordinary schooling apart. The money is meant to restore learning, provide catch-up classes...

Continue Reading
Workers Are Burning Savings as Pay Falls Behind Costs

Updated Category News Views 69

Payroll optimism has been ground into dust by the ordinary bills nobody can dodge. Monster's 2026 Cost of Living Report says 93% of employed U.S. workers feel their wages are failing to keep up with costs, barely different from 95% in both 2024 and 2025. That is not a blip, and it is not workers merely grousing about prices. Three years of nearly identical frustration...

Continue Reading

Top 5 Most Recently Viewed Articles

Alphabet's Q2 Earnings: AI Insights and Market Reactions Await

Updated Category News Views 187

Alphabet's Q2 Earnings Report: A Focus on AI Growth Alphabet (NASDAQ: GOOGL), the parent company of Google, is poised to release its second quarter earnings soon. Many analysts and investors are keenly awaiting details that might reveal how the company’s artificial intelligence (AI) endeavors are transforming into tangible revenue streams. With the surge in interest...

Continue Reading
Join the Class Action Against Dentsply Sirona for Investor Rights

Updated Category News Views 91

Important Notice for Dentsply Sirona Inc. Shareholders The Gross Law Firm has issued a notice for shareholders of Dentsply Sirona Inc. (NASDAQ: XRAY). Shareholders who acquired shares during the recently identified class period are encouraged to reach out regarding the opportunity to be appointed as lead plaintiff. Securing this position is not a prerequisite for...

Continue Reading
Major Insider Sale by James Davis at American Woodmark Revealed

Updated Category News Views 447

Insider Activity Spotlight on American Woodmark James Davis, a Board Member of American Woodmark (NASDAQ: AMWD), has made headlines recently by selling a significant number of shares, which has sparked various reactions in the market. Understanding Recent Transactions: In a recent SEC filing, it was reported that DAVIS sold 1,250 shares of American Woodmark, amounting to...

Continue Reading
Ivybrook's $5K Franchise Incentive Targets Educators

Updated Category News Views 28

Franchise ownership might just feel within reach for educators eying a new chapter, thanks to Ivybrook Academy’s fresh incentive. The renowned half-day preschool franchise is now offering a cool $5,000 cut off the initial franchise fee to educators diving into franchise ownership. It’s a nod to those who spend their days molding young minds. Opening Doors for...

Continue Reading
NOAA Taps ICEYE US for Game-Changing SAR Satellite Data

Updated Category News Views 61

The Strategic Move to SAR Data Imagine this: You’re in the thick of a hurricane, where visibility goes out the window, and traditional satellite data chokes under the crushing weight of clouds and nightfall. That's the precise chaos ICEYE US is cutting through with its Synthetic Aperture Radar (SAR) technology. The latest scuttlebutt is that NOAA's getting cozy with...

Continue Reading